A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors
- PMID: 27910095
- PMCID: PMC5368013
- DOI: 10.1111/trf.13939
A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors
Abstract
Background: The incidence of human immunodeficiency virus (HIV) in repeat blood donors has been estimated using seven methods. Although incidence is always calculated as cases per person-time, approaches to selecting cases and calculating person-time vary. Incidence estimates have not been compared among methods.
Study design and methods: The seven methods were compared in a simulation study. Because three methods used information from donations made before an estimation interval, 8 years of donation and infection history were simulated, and Years 7 and 8 were treated as the estimation interval for all methods. An exponential random variate was assigned to each donor to simulate the time to infection. Infection risk was constant over 8 years in one scenario but increased at various rates in seven other scenarios. The infection risk scenarios were combined with four mixes of donation frequency to generate 32 test conditions.
Results: Three methods produced biased estimates under all conditions. Three other methods were biased under most conditions. Bias from most methods increased as donation frequency declined. The single method that consistently produced unbiased estimates was the only method that involved the standard epidemiological approach of tabulating all interdonation intervals (IDIs) within the estimation interval. Bias was eliminated from one of the consistently biased methods by a simple modification that involved the average IDI in a sample of donors.
Conclusion: The standard epidemiological approach is recommended if required data are available. Otherwise, the modified method involving the estimated average IDI should be considered. Investigators should use caution when comparing incidence estimates among studies that use different estimation methods or donation frequencies.
© 2016 AABB.
Conflict of interest statement
The authors declare that they have no conflicts of interest relevant to the manuscript submitted to TRANSFUSION
Figures



References
-
- Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ for the Retrovirus Epidemiology Donor Study. The Risk of Transfusion-Transmitted Viral Infections. N Engl J Med. 1996;334:1685–1690. - PubMed
-
- Kleinman SH, Busch MP, Korelitz JJ, Schreiber GB. The incidence/window period model and its use to assess the risk of transfusion-transmitted HIV and HCV infection. Transfus Med Rev. 1997;11:155–172. - PubMed
-
- Wang B, Schreiber GB, Glynn SA, et al. for the Retrovirus Epidemiology Donor Study. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors? Transfusion. 2005;45:1089–1096. - PubMed
-
- Adeoti FM, Oyourou AO, Sirancy, et al. Evolution of the Residual Risk of Transmitting HIV, HCV and HBV in the Blood Transfusion from 1998 to 2009 in Cote d’Ivoire. J Vaccines Vaccin. 2012;3:1–4.
-
- Mapako T, Mvere DA, Chitiyo ME, et al. Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety. Transfusion. 2013;53:2413–2421. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical